Effect of MD1003 (high dose pharmaceutical grade Biotin) for the treatment of progressive MS: long-term safety data at 48 months of follow-up

Affiliation auteurs!!!! Error affiliation !!!!
TitreEffect of MD1003 (high dose pharmaceutical grade Biotin) for the treatment of progressive MS: long-term safety data at 48 months of follow-up
Type de publicationJournal Article
Year of Publication2019
AuteursDe Seze J., Edan G., Moreau T., Sedel F., Tourbah A., Krijnen E.
JournalEUROPEAN JOURNAL OF NEUROLOGY
Volume26
Pagination860
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN1351-5101